Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orgenesis Gross Profit 2013-2024 | ORGS

Orgenesis gross profit from 2013 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
Orgenesis Annual Gross Profit
(Millions of US $)
2023 $-6
2022 $31
2021 $-1
2020 $-76
2019 $-10
2018 $8
2018 $8
2017 $3
2016 $-1
2015 $-1
2014 $
2013 $
2012 $
2012 $
2011 $
Orgenesis Quarterly Gross Profit
(Millions of US $)
2024-09-30 $-5
2024-06-30 $-2
2024-03-31 $-3
2023-12-31 $8
2023-09-30 $-1
2023-06-30 $-7
2023-03-31 $-6
2022-12-31 $11
2022-09-30 $7
2022-06-30 $6
2022-03-31 $6
2021-12-31 $-4
2021-09-30 $-1
2021-06-30 $1
2021-03-31 $3
2020-12-31 $-45
2020-09-30 $-5
2020-06-30 $-23
2020-03-31 $-3
2019-12-31 $-2
2019-09-30 $-1
2019-06-30 $-2
2019-03-31 $-5
2018-12-31 $3
2018-11-30
2018-08-31 $3
2018-05-31 $2
2018-02-28 $1
2017-11-30
2017-08-31 $1
2017-05-31 $1
2017-02-28 $-0
2016-11-30
2016-08-31 $0
2016-05-31 $-1
2016-02-29 $0
2015-11-30
2015-08-31 $-0
2015-05-31 $-0
2015-02-28
2014-11-30
2014-08-31
2014-05-31
2014-02-28
2013-11-30
2013-08-31
2013-05-31
2013-02-28
2012-12-31
2012-11-30
2012-09-30
2012-08-31
2012-06-30
2012-05-31
2012-03-31
2012-02-29
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.005B $0.001B
Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing Organization and Cellular Therapy Business. Contract Development and Manufacturing Organization segment activity includes MaSTherCell, which specializes in cell therapy development for advanced medicinal products. Cellular Therapy Business segment activity is based on its technology which demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes. Orgenesis, Inc. is headquartered in Germantown, MD.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.467B 14.08
Vertex Pharmaceuticals (VRTX) United States $119.424B 0.00
Gilead Sciences (GILD) United States $114.476B 20.73
Bristol Myers Squibb (BMY) United States $113.132B 47.68
CSL (CSLLY) Australia $84.940B 0.00
Regeneron Pharmaceuticals (REGN) United States $80.363B 18.29
GSK (GSK) United Kingdom $70.363B 8.14
Argenex SE (ARGX) Netherlands $36.656B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.657B 0.00
BioNTech SE (BNTX) Germany $28.617B 0.00
Illumina (ILMN) United States $22.818B 83.16
Biogen (BIIB) United States $21.862B 9.39
BeiGene (BGNE) Cayman Islands $17.475B 0.00
Moderna (MRNA) United States $16.097B 0.00
Genmab (GMAB) Denmark $13.348B 19.58
Incyte (INCY) United States $13.206B 0.00
Insmed (INSM) United States $12.815B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.580B 29.21
Bio-Techne Corp (TECH) United States $12.027B 46.44
Sarepta Therapeutics (SRPT) United States $11.817B 106.65
Exact Sciences (EXAS) United States $11.336B 0.00
Vaxcyte (PCVX) United States $10.933B 0.00
QIAGEN (QGEN) Netherlands $10.360B 21.31
Exelixis (EXEL) United States $10.004B 22.75
Bio-Rad Laboratories (BIO.B) United States $9.437B 32.07
Intra-Cellular Therapies (ITCI) United States $8.803B 0.00
Repligen (RGEN) United States $8.763B 114.17
Roivant Sciences (ROIV) United Kingdom $8.619B 0.00
Ascendis Pharma (ASND) Denmark $7.876B 0.00
Revolution Medicines (RVMD) United States $7.572B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.438B 7.28
Legend Biotech (LEGN) United States $6.414B 0.00
Nuvalent (NUVL) United States $6.172B 0.00
Halozyme Therapeutics (HALO) United States $6.107B 13.79
Blueprint Medicines (BPMC) United States $5.920B 0.00
Cytokinetics (CYTK) United States $5.741B 0.00
Telix Pharmaceuticals (TLX) Australia $5.275B 0.00
Viking Therapeutics (VKTX) United States $5.241B 0.00
TG Therapeutics (TGTX) United States $4.984B 0.00
Alkermes (ALKS) Ireland $4.937B 16.58
Krystal Biotech (KRYS) United States $4.706B 77.92
Arcellx (ACLX) United States $4.531B 0.00
ADMA Biologics Inc (ADMA) United States $4.394B 46.47
Axsome Therapeutics (AXSM) United States $4.366B 0.00
Guardant Health (GH) United States $4.295B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.228B 0.00
Apellis Pharmaceuticals (APLS) United States $4.129B 0.00
Scholar Rock Holding (SRRK) United States $3.930B 0.00
Biohaven (BHVN) United States $3.890B 0.00
Avidity Biosciences (RNA) United States $3.876B 0.00
Immunovant (IMVT) United States $3.858B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.737B 0.00
NovoCure (NVCR) Jersey $3.615B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.395B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.365B 0.00
Denali Therapeutics (DNLI) United States $3.306B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.281B 0.00
Janux Therapeutics (JANX) United States $3.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.053B 0.00
Merus (MRUS) Netherlands $2.932B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.860B 0.00
SpringWorks Therapeutics (SWTX) United States $2.849B 0.00
Vericel (VCEL) United States $2.837B 957.83
Twist Bioscience (TWST) United States $2.819B 0.00
Amicus Therapeutics (FOLD) United States $2.797B 0.00
Vera Therapeutics (VERA) United States $2.789B 0.00
Kymera Therapeutics (KYMR) United States $2.729B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.719B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.716B 0.00
Edgewise Therapeutics (EWTX) United States $2.615B 0.00
Protagonist Therapeutics (PTGX) United States $2.448B 15.44
Iovance Biotherapeutics (IOVA) United States $2.386B 0.00
Geron (GERN) United States $2.333B 0.00
Beam Therapeutics (BEAM) United States $2.313B 0.00
NeoGenomics (NEO) United States $2.276B 0.00
Agios Pharmaceuticals (AGIO) United States $2.222B 0.00
Ligand Pharmaceuticals (LGND) United States $2.209B 55.15
IDEAYA Biosciences (IDYA) United States $2.177B 0.00
Bavarian Nordic (BVNRY) Denmark $2.155B 13.20
WAVE Life Sciences (WVE) Singapore $2.050B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.037B 0.00
Akero Therapeutics (AKRO) United States $2.016B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.007B 0.00
Apogee Therapeutics (APGE) United States $2.004B 0.00
ImmunityBio (IBRX) United States $2.000B 0.00
CG Oncology (CGON) United States $1.945B 0.00
Disc Medicine (IRON) United States $1.931B 0.00
Belite Bio (BLTE) United States $1.908B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.847B 15.35
Certara (CERT) United States $1.846B 52.14
MannKind (MNKD) United States $1.804B 46.71
Fortrea Holdings (FTRE) United States $1.794B 57.14
Structure Therapeutics (GPCR) United States $1.789B 0.00
Galapagos (GLPG) Belgium $1.767B 0.00
Dynavax Technologies (DVAX) United States $1.704B 99.69
Celldex Therapeutics (CLDX) United States $1.686B 0.00
Neumora Therapeutics (NMRA) United States $1.667B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.485B 0.00
Arcus Biosciences (RCUS) United States $1.472B 0.00
Novavax (NVAX) United States $1.459B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.458B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.446B 0.00
Nurix Therapeutics (NRIX) United States $1.436B 0.00
Viridian Therapeutics (VRDN) United States $1.414B 0.00
Travere Therapeutics (TVTX) United States $1.352B 0.00
MiMedx (MDXG) United States $1.346B 35.23
Mesoblast (MESO) Australia $1.343B 0.00
Arvinas (ARVN) United States $1.340B 0.00
Intellia Therapeutics (NTLA) United States $1.314B 0.00
Myriad Genetics (MYGN) United States $1.314B 0.00
Praxis Precision Medicines (PRAX) United States $1.308B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.286B 0.00
Spyre Therapeutics (SYRE) United States $1.241B 0.00
ANI Pharmaceuticals (ANIP) United States $1.190B 16.21
Syndax Pharmaceuticals (SNDX) United States $1.189B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.096B 0.00
Upstream Bio (UPB) United States $1.085B 0.00
Vir Biotechnology (VIR) United States $1.026B 0.00
Septerna (SEPN) United States $0.994B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.954B 0.00
Bicara Therapeutics (BCAX) United States $0.952B 0.00
Poseida Therapeutics (PSTX) United States $0.930B 0.00
Adaptive Biotechnologies (ADPT) United States $0.930B 0.00
Liquidia Technologies (LQDA) United States $0.924B 0.00
Pacira BioSciences (PCRX) United States $0.917B 8.63
Gyre Therapeutics (GYRE) United States $0.902B 0.00
ArriVent BioPharma (AVBP) United States $0.900B 0.00
Cogent Biosciences (COGT) United States $0.900B 0.00
Nuvation Bio (NUVB) United States $0.878B 0.00
Zymeworks (ZYME) United States $0.866B 0.00
Immatics (IMTX) Germany $0.861B 0.00
Replimune (REPL) United States $0.859B 0.00
LENZ Therapeutics (LENZ) United States $0.852B 0.00
AbCellera Biologics (ABCL) Canada $0.830B 0.00
89BIO (ETNB) United States $0.816B 0.00
Pliant Therapeutics (PLRX) United States $0.809B 0.00
Castle Biosciences (CSTL) United States $0.809B 144.35
Cytek Biosciences (CTKB) United States $0.800B 0.00
Avid Bioservices (CDMO) United States $0.789B 0.00
Immunome (IMNM) United States $0.785B 0.00
Keros Therapeutics (KROS) United States $0.763B 0.00
Tyra Biosciences (TYRA) United States $0.756B 0.00
UniQure (QURE) Netherlands $0.751B 0.00
Kura Oncology (KURA) United States $0.749B 0.00
GRAIL (GRAL) United States $0.745B 0.00
Erasca (ERAS) United States $0.724B 0.00
Anavex Life Sciences (AVXL) United States $0.717B 0.00
CureVac (CVAC) Germany $0.707B 5.75
Dianthus Therapeutics (DNTH) United States $0.705B 0.00
Oculis Holding AG (OCS) Switzerland $0.692B 0.00
Prothena (PRTA) Ireland $0.688B 0.00
Rapport Therapeutics (RAPP) United States $0.687B 0.00
Cullinan Therapeutics (CGEM) United States $0.684B 0.00
Tectonic Therapeutic (TECX) United States $0.669B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Entrada Therapeutics (TRDA) United States $0.661B 11.11
Arbutus Biopharma (ABUS) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.639B 0.00
MBX Biosciences (MBX) United States $0.633B 0.00
CARGO Therapeutics (CRGX) United States $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.609B 0.00
Oric Pharmaceuticals (ORIC) United States $0.601B 0.00
Mineralys Therapeutics (MLYS) United States $0.592B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.580B 0.00
Terns Pharmaceuticals (TERN) United States $0.572B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.543B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.539B 0.00
Astria Therapeutics (ATXS) United States $0.537B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.525B 0.00
Humacyte (HUMA) United States $0.516B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.509B 0.00
CorMedix Inc (CRMD) United States $0.508B 0.00
Third Harmonic Bio (THRD) United States $0.507B 0.00
PureTech Health (PRTC) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.478B 0.00
Cartesian Therapeutics (RNAC) United States $0.475B 0.00
AnaptysBio (ANAB) United States $0.474B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.474B 0.00
Annexon (ANNX) United States $0.473B 0.00
ChromaDex (CDXC) United States $0.467B 612.00
Arcturus Therapeutics Holdings (ARCT) United States $0.466B 0.00
Celcuity (CELC) United States $0.465B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.464B 0.00
Emergent Biosolutions (EBS) United States $0.459B 0.00
MaxCyte (MXCT) United States $0.452B 0.00
Abivax SA (ABVX) France $0.450B 0.00
Codexis (CDXS) United States $0.450B 0.00
Kodiak Sciences (KOD) United States $0.446B 0.00
Alpha Teknova (TKNO) United States $0.428B 0.00
Sangamo Therapeutics (SGMO) United States $0.428B 0.00
IGM Biosciences (IGMS) United States $0.426B 0.00
Absci (ABSI) United States $0.424B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.422B 0.00
Sana Biotechnology (SANA) United States $0.422B 0.00
Aura Biosciences (AURA) United States $0.420B 0.00
REGENXBIO (RGNX) United States $0.410B 0.00
GH Research (GHRS) Ireland $0.403B 0.00
Allogene Therapeutics (ALLO) United States $0.396B 0.00
Alumis (ALMS) United States $0.396B 0.00
Olema Pharmaceuticals (OLMA) United States $0.387B 0.00
Northwest Biotherapeutics (NWBO) United States $0.385B 0.00
Prime Medicine (PRME) United States $0.378B 0.00
Zenas BioPharma (ZBIO) United States $0.373B 0.00
Contineum Therapeutics (CTNM) United States $0.362B 0.00
Neurogene (NGNE) United States $0.349B 0.00
Voyager Therapeutics (VYGR) United States $0.343B 8.83
Kamada (KMDA) Israel $0.337B 20.96
Sage Therapeutics (SAGE) United States $0.329B 0.00
Tango Therapeutics (TNGX) United States $0.329B 0.00
ACELYRIN, INC (SLRN) United States $0.324B 0.00
Revance Therapeutics (RVNC) United States $0.323B 0.00
Trevi Therapeutics (TRVI) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
Eton Pharmaceuticals (ETON) United States $0.319B 0.00
Prima BioMed (IMMP) Australia $0.317B 0.00
Design Therapeutics (DSGN) United States $0.317B 0.00
C4 Therapeutics (CCCC) United States $0.309B 0.00
Jasper Therapeutics (JSPR) United States $0.309B 0.00
Foghorn Therapeutics (FHTX) United States $0.295B 0.00
AC Immune (ACIU) Switzerland $0.292B 0.00
BioStem Technologies (BSEM) $0.286B 25.31
ITeos Therapeutics (ITOS) United States $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.280B 0.00
Renovaro (RENB) United States $0.279B 0.00
Benitec Biopharma (BNTC) United States $0.273B 0.00
EnGene Holdings (ENGN) Canada $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.269B 0.00
Urogen Pharma (URGN) United States $0.266B 0.00
Rezolute (RZLT) United States $0.266B 0.00
Mersana Therapeutics (MRSN) United States $0.266B 0.00
Chimerix (CMRX) United States $0.265B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.262B 0.00
Artiva Biotherapeutics (ARTV) United States $0.258B 0.00
ATyr Pharma (ATYR) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Anika Therapeutics (ANIK) United States $0.251B 0.00
Ocugen (OCGN) United States $0.250B 0.00
Atea Pharmaceuticals (AVIR) United States $0.247B 0.00
Nautilus Biotechnology (NAUT) United States $0.245B 0.00
Innate Pharma S.A (IPHA) France $0.245B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.231B 0.00
DiaMedica Therapeutics (DMAC) United States $0.230B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.220B 0.00
Candel Therapeutics (CADL) United States $0.219B 0.00
Molecular Partners AG (MOLN) Switzerland $0.219B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
Fulcrum Therapeutics (FULC) United States $0.214B 0.00
XBiotech (XBIT) United States $0.212B 0.00
Inhibrx Biosciences (INBX) United States $0.212B 0.00
Gossamer Bio (GOSS) United States $0.211B 0.00
TuHURA Biosciences (HURA) United States $0.208B 0.00
Fate Therapeutics (FATE) United States $0.208B 0.00
Biomea Fusion (BMEA) United States $0.204B 0.00
Compass Therapeutics (CMPX) United States $0.201B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.200B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.200B 0.00
Verastem (VSTM) United States $0.199B 0.00
Precigen (PGEN) United States $0.198B 0.00
Solid Biosciences (SLDB) United States $0.196B 0.00
Inozyme Pharma (INZY) United States $0.195B 0.00
Alector (ALEC) United States $0.193B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
Kyverna Therapeutics (KYTX) United States $0.191B 0.00
Opthea (OPT) Australia $0.190B 0.00
Amarin (AMRN) Ireland $0.187B 0.00
Coherus BioSciences (CHRS) United States $0.185B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.179B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Semper Paratus Acquisition (TVGN) United States $0.175B 0.00
Sutro Biopharma (STRO) United States $0.175B 0.00
Climb Bio (CLYM) United States $0.175B 0.00
Caribou Biosciences (CRBU) United States $0.173B 0.00
2seventy Bio (TSVT) United States $0.169B 0.00
Actuate Therapeutics (ACTU) United States $0.168B 0.00
Adherex Technologies (FENC) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.161B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
ScPharmaceuticals (SCPH) United States $0.160B 0.00
CAMP4 Therapeutics (CAMP) United States $0.154B 0.00
BioAge Labs (BIOA) United States $0.153B 0.00
PepGen (PEPG) United States $0.153B 0.00
TScan Therapeutics (TCRX) United States $0.152B 0.00
Seres Therapeutics (MCRB) United States $0.150B 0.00
Zura Bio (ZURA) United States $0.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
Seer (SEER) United States $0.146B 0.00
Black Diamond Therapeutics (BDTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.144B 80.50
Instil Bio (TIL) United States $0.143B 0.00
Elutia (ELUT) United States $0.143B 0.00
Puma Biotechnology (PBYI) United States $0.141B 6.00
InflaRx (IFRX) Germany $0.139B 0.00
Cabaletta Bio (CABA) United States $0.138B 0.00
Sagimet Biosciences (SGMT) United States $0.135B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
Applied Therapeutics (APLT) United States $0.134B 0.00
Inventiva S.A (IVA) France $0.129B 0.00
Aligos Therapeutics (ALGS) United States $0.122B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.122B 0.00
Editas Medicine (EDIT) United States $0.119B 0.00
X4 Pharmaceuticals (XFOR) United States $0.114B 0.00
Leap Therapeutics (LPTX) United States $0.113B 0.00
Akoya Biosciences (AKYA) United States $0.113B 0.00
Adverum Biotechnologies (ADVM) United States $0.112B 0.00
TELA Bio (TELA) United States $0.109B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Alto Neuroscience (ANRO) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Skye Bioscience (SKYE) United States $0.103B 0.00
Immunic (IMUX) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
HilleVax (HLVX) United States $0.098B 0.00
Scilex Holding (SCLX) United States $0.097B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.096B 0.00
Rani Therapeutics Holdings (RANI) United States $0.095B 0.00
Invizyne Technologies (IZTC) United States $0.095B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.094B 0.00
Genenta Science S.p.A (GNTA) Italy $0.094B 0.00
Allakos (ALLK) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Nuvectis Pharma (NVCT) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.089B 0.00
23andMe Holding (ME) United States $0.088B 0.00
CytomX Therapeutics (CTMX) United States $0.087B 6.53
Adlai Nortye (ANL) Cayman Islands $0.085B 0.00
I-Mab (IMAB) China $0.082B 0.00
Vigil Neuroscience (VIGL) United States $0.081B 0.00
Genelux (GNLX) United States $0.080B 0.00
Ikena Oncology (IKNA) United States $0.080B 0.00
Adicet Bio (ACET) United States $0.080B 0.00
Abpro Holdings (ABP) United States $0.079B 0.00
Generation Bio (GBIO) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
FibroBiologics (FBLG) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
Repare Therapeutics (RPTX) Canada $0.075B 0.00
Werewolf Therapeutics (HOWL) United States $0.074B 0.00
DBV Technologies S.A (DBVT) France $0.073B 0.00
Annovis Bio (ANVS) United States $0.073B 0.00
Ovid Therapeutics (OVID) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Agenus (AGEN) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.070B 0.00
BioAtla (BCAB) United States $0.070B 0.00
Theratechnologies (THTX) Canada $0.070B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.069B 0.00
PDS Biotechnology (PDSB) United States $0.069B 0.00
Vor Biopharma (VOR) $0.068B 0.00
VistaGen Therapeutics (VTGN) United States $0.068B 0.00
Invivyd (IVVD) United States $0.065B 0.00
BeyondSpring (BYSI) United States $0.064B 0.00
Oncolytics Biotech (ONCY) Canada $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Galena Biopharma (SLS) United States $0.061B 0.00
Inovio Pharmaceuticals (INO) United States $0.061B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.060B 0.00
Aadi Bioscience (AADI) United States $0.059B 0.00
Kronos Bio (KRON) United States $0.059B 0.00
Spero Therapeutics (SPRO) United States $0.058B 15.29
Immix Biopharma (IMMX) United States $0.056B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.056B 0.00
Boundless Bio (BOLD) United States $0.055B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.054B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Omega Therapeutics (OMGA) United States $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
IO Biotech (IOBT) Denmark $0.053B 0.00
Enzo Biochem (ENZ) United States $0.053B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.051B 0.00
Immuneering (IMRX) United States $0.051B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Celularity (CELU) United States $0.049B 0.00
Dyadic (DYAI) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Passage Bio (PASG) United States $0.047B 0.00
Exicure (XCUR) United States $0.045B 0.00
Q32 Bio (QTTB) United States $0.045B 0.00
Rallybio (RLYB) United States $0.045B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
AN2 Therapeutics (ANTX) United States $0.043B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.042B 0.00
Precision BioSciences (DTIL) United States $0.042B 0.00
Clene (CLNN) United States $0.041B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.041B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
SAB Biotherapeutics (SABS) United States $0.038B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.036B 0.00
Grace Therapeutics (GRCE) Canada $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Affimed (AFMD) Germany $0.035B 0.00
Forte Biosciences (FBRX) United States $0.034B 0.00
Beyond Air (XAIR) United States $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Alpha Cognition (ACOG) Canada $0.033B 0.00
Opus Genetics (IRD) United States $0.032B 0.00
Rapt Therapeutics (RAPT) United States $0.032B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
NextCure (NXTC) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
KALA BIO (KALA) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Gelteq (GELS) Australia $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
Senti Biosciences (SNTI) United States $0.026B 0.00
Equillium (EQ) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
MiNK Therapeutics (INKT) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.024B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
LakeShore Biopharma (LSB) China $0.023B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Athira Pharma (ATHA) United States $0.023B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
IN8bio (INAB) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
UNITY Biotechnology (UBX) United States $0.019B 0.00
MetaVia (MTVA) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Cara Therapeutics (CARA) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Imunon (IMNN) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.012B 0.00
CervoMed (CRVO) United States $0.012B 0.00
Aptose Biosciences (APTO) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Mainz Biomed (MYNZ) Germany $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Apollomics (APLM) United States $0.009B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Quantum Biopharma (QNTM) Canada $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.007B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Evaxion Biotech (EVAX) Denmark $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Carmell (CTCX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Palisade Bio (PALI) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
AquaBounty Technologies (AQB) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00